Estrogen research. Brain researchers try to salvage estrogen treatments.
Wickelgren
Ingrid
I
D000367:Age Factors; D000368:Aged; D000818:Animals; D001921:Brain / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects; D003704:Dementia / Q000209:etiology*; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000494:pharmacology*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology*; D008875:Middle Aged; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology; D018579:Patient Selection; D011374:Progesterone / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced / Q000150:complications; D013997:Time Factors
D004338:Drug Combinations; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D018696:Neuroprotective Agents; C466383:Prempro; D011374:Progesterone; D017258:Medroxyprogesterone Acetate